×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| MOREPEN LABORATORIES LTD. | 4581.18 | 266.89 | 4527.81 | 0.49 | 2,836 | 22.5 |
| GUJARAT THEMIS BIOSYN LTD. | 397.61 | 129.72 | 395.20 | 1.19 | 2663 | 50.6 |
| SUVEN LIFE SCIENCES LTD. | 32.4 | -391.17 | 16.1 | -1.79 | 2565 |
Morepen Laboratories Ltd., with Security Code 500288, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274.3 | 383.3 | 344.6 | 336.5 | 369.1 | 381.2 | 394.6 | 392.6 | 385.6 | 383.7 |
| Expenses | 260.8 | 356.3 | 323.2 | 321.4 | 344.3 | 351.5 | 343.5 | 336.5 | 337.0 | 340.6 |
| Operating Profit | 13.6 | 27.1 | 21.4 | 15.1 | 24.8 | 29.8 | 51.1 | 56.1 | 48.6 | 43.1 |
| OPM % | 4.96% | 7.07% | 6.22% | 4.5% | 6.72% | 7.81% | 12.95% | 14.3% | 12.6% | 11.22% |
| Other Income | 0.7 | 0.9 | 1.2 | 3.0 | 2.1 | 2.8 | 3.7 | 4.0 | 3.1 | 4.6 |
| Interest | 0.4 | 0.5 | 0.6 | 0.6 | 0.3 | 0.5 | 2.0 | 0.7 | 1.0 | 1.1 |
| Depreciation | 4.4 | 4.5 | 4.6 | 4.6 | 4.9 | 4.8 | 5.5 | 6.7 | 3.6 | 3.8 |
| Profit before tax | 9.6 | 23.0 | 17.5 | 12.9 | 21.7 | 27.3 | 47.2 | 52.7 | 47.0 | 42.9 |
| Tax % | 28% | 28.2% | 28.3% | 20.6% | 27% | 27.1% | 25.5% | 24.2% | 25.5% | 25.5% |
| Net Profit | 6.9 | 16.5 | 12.6 | 10.3 | 15.9 | 19.9 | 35.2 | 40.0 | 35.1 | 31.9 |
| EPS in Rs | 0.13 | 0.35 | 0.24 | 0.2 | 0.31 | 0.39 | 0.69 | 0.78 | 0.69 | 0.6 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 403.0 | 348.5 | 363.7 | 401.0 | 421.8 | 444.6 | 423.1 | 455.2 | 437.7 | 452.8 |
| Expenses | 374.1 | 328.0 | 348.1 | 375.0 | 388.2 | 394.0 | 375.2 | 403.6 | 393.7 | 416.6 |
| Operating Profit | 28.9 | 20.5 | 15.6 | 26.1 | 33.6 | 50.6 | 47.9 | 51.6 | 44.1 | 36.1 |
| OPM % | 7.2% | 5.9% | 4.3% | 6.5% | 8% | 11.4% | 11.3% | 11.3% | 10.1% | 8% |
| Other Income | 0.9 | 1.2 | 3.1 | 2.4 | 3.2 | 4.1 | 4.2 | 3.4 | 5.0 | 5.3 |
| Interest | 0.5 | 0.6 | 0.6 | 0.3 | 0.5 | 2.2 | 0.8 | 1.2 | 1.2 | 1.3 |
| Depreciation | 7.0 | 7.2 | 7.0 | 7.7 | 7.7 | 8.4 | 9.6 | 5.7 | 1.9 | 4.9 |
| Profit before tax | 22.3 | 14.0 | 11.1 | 20.5 | 28.7 | 44.0 | 41.7 | 48.2 | 46.0 | 35.2 |
| Tax % | 29.1% | 35.8% | 26% | 28.7% | 25.9% | 27.3% | 31.9% | 24.9% | 24.3% | 24.2% |
| Net Profit | 15.8 | 9.0 | 8.2 | 14.6 | 21.3 | 32.0 | 28.3 | 36.2 | 34.8 | 26.7 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 11% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 31% |
| 3 Years: | 6% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 30% |
| 3 Years: | 8% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 27% |
| 3 Years: | 0% |
| TTM: | 66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 30% |
| 3 Years: | 8% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|